Department of Gastroenterology, Toyoshima Endoscopy Clinic, Tokyo, Japan.
Department of Gastroenterology and Hepatology, International University of Health and Welfare, Narita Hospital, Narita, Japan.
J Gastroenterol Hepatol. 2022 Feb;37(2):291-300. doi: 10.1111/jgh.15693. Epub 2021 Oct 6.
Two methods are used to evaluate gastritis: the updated Sydney system (USS) with pathology and Kyoto classification, a new endoscopy-based diagnostic criterion for which evidence is accumulating. However, the consistency of their results is unclear. This study investigated the consistency of their results.
Patients who underwent esophagogastroduodenoscopy and were evaluated for Helicobacter pylori infection for the first time were eligible. The association between corpus and antral USS scores (neutrophil activity, chronic inflammation, atrophy, and intestinal metaplasia) and Kyoto classification scores (atrophy, intestinal metaplasia, enlarged folds, nodularity, and diffuse redness) was assessed.
Seven-hundred-seventeen patients (mean age, 49.2 years; female sex, 57.9%; 450 H. pylori-positive and 267 H. pylori-negative patients) were enrolled. All endoscopic gastritis cases in the Kyoto classification were associated with high corpus and antral USS scores for neutrophil activity and chronic inflammation. A subanalysis was performed for H. pylori-positive patients. Regarding atrophy and intestinal metaplasia, endoscopic findings were associated with USS scores. Enlarged folds, nodularity, and diffuse redness were associated with high corpus USS scores for neutrophil activity and chronic inflammation, but with low antral USS scores for atrophy and intestinal metaplasia. The Kyoto classification scores were also associated with the pathological topographic distribution of neutrophil activity and intestinal metaplasia.
Among H. pylori-positive individuals, endoscopic and pathological diagnoses were consistent with atrophy and intestinal metaplasia. Enlarged folds, nodularity, and diffuse redness were associated with pathological inflammation (neutrophil activity and chronic inflammation) of the corpus; however, they were inversely associated with pathological atrophy and intestinal metaplasia. The endoscopy-based Kyoto classification of gastritis partially reflects pathology.
有两种方法用于评估胃炎:更新后的悉尼系统(USS)结合病理学和京都分类,这是一种新的基于内镜的诊断标准,其证据正在不断积累。然而,它们的结果一致性尚不清楚。本研究旨在探讨它们结果的一致性。
符合首次接受食管胃十二指肠镜检查和幽门螺杆菌感染评估的患者。评估胃体和胃窦 USS 评分(中性粒细胞活性、慢性炎症、萎缩和肠化生)与京都分类评分(萎缩、肠化生、皱襞增大、结节和弥漫性发红)之间的相关性。
共纳入 717 例患者(平均年龄 49.2 岁;女性占 57.9%;450 例幽门螺杆菌阳性和 267 例幽门螺杆菌阴性患者)。京都分类的所有内镜胃炎病例均与胃体和胃窦 USS 评分的中性粒细胞活性和慢性炎症高度相关。对幽门螺杆菌阳性患者进行了亚分析。对于萎缩和肠化生,内镜发现与 USS 评分相关。皱襞增大、结节和弥漫性发红与胃体 USS 评分的中性粒细胞活性和慢性炎症相关,但与胃窦 USS 评分的萎缩和肠化生相关。京都分类评分也与中性粒细胞活性和肠化生的病理分布相关。
在幽门螺杆菌阳性个体中,内镜和病理诊断与萎缩和肠化生一致。皱襞增大、结节和弥漫性发红与胃体的炎症(中性粒细胞活性和慢性炎症)相关,但与胃窦的萎缩和肠化生呈负相关。基于内镜的胃炎京都分类部分反映了病理学。